
Twelve years of multiples investors have paid for Omaxe Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Twelve years of audited numbers for Omaxe Ltd, switchable between annual and quarterly views, consolidated or standalone.
Omaxe Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,382 Cr and reported EPS of ₹-38.10.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,839 | 1,167 | 1,121 | 476 | 618 | 773 | 1,614 | 1,561 | 1,253 |
| Other Income | 59 | 34 | 34 | 39 | 20 | 25 | 21 | 76 | 86 |
| Total Income | 1,898 | 1,200 | 1,156 | 515 | 638 | 798 | 1,635 | 1,637 | 1,340 |
| Cost of Goods Sold (COGS) | 1,412 | 878 | 786 | 473 | 558 | 866 | 1,789 | 2,011 | 1,762 |
| Gross Profit | 427 | 289 | 336 | 2 | 60 | -93 | -175 | -450 | -509 |
| +Operating Expenses | 167 | 161 | 145 | 121 | 107 | 210 | 168 | 158 | 187 |
| EBITDA | 260 | 128 | 191 | -119 | -47 | -303 | -343 | -608 | -696 |
| +Non-Operating Expenses | 178 | 83 | 181 | 225 | 168 | 178 | 185 | 232 | 290 |
| Profit Before Tax (PBT) | 141 | 79 | 44 | -305 | -194 | -457 | -507 | -764 | -899 |
| +Tax Expense | 56 | 30 | 141 | -69 | -33 | -106 | -101 | -79 | -202 |
| Profit After Tax (PAT) | 85 | 49 | -97 | -235 | -162 | -351 | -406 | -685 | -697 |
| Earnings Per Share (EPS) | 4.59 | 2.68 | -5.32 | -12.86 | -8.72 | -19.02 | -22.01 | -37.51 | -38.10 |
| Diluted Shares Outstanding (Nos.) | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| +Additional Disclosures | 3,169 | 1,999 | 1,897 | 1,294 | 1,387 | 2,119 | 3,928 | 4,412 | 4,001 |
| Sales Growth % | — | -36.57 | -3.86 | -57.58 | 29.87 | 25.17 | 108.75 | -3.30 | -19.70 |
| YoY Sales Growth % | — | -36.57 | -3.86 | -57.58 | 29.87 | 25.17 | 108.75 | -3.30 | -19.70 |
| Material Cost % | 104 | 169 | 90 | 157 | 183 | 232 | 96 | 134 | 224 |
| Employee Cost % | 3 | 6 | 5 | 7 | 7 | 5 | 2 | 2 | 2 |
| Other Cost % | 6 | 8 | 8 | 18 | 11 | 22 | 8 | 9 | 13 |
| OPM % | 14 | 11 | 17 | -25 | -8 | -39 | -21 | -39 | -56 |
| Tax % | 39 | 38 | 319 | 23 | 17 | 23 | 20 | 10 | 23 |
| Profit Growth % | — | -42.88 | -299.67 | -142.14 | 31.29 | -117.24 | -15.62 | -68.86 | -1.66 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Additional Fields | 251 | 119 | 118 | -182 | -93 | -369 | -398 | -644 | -730 |
Disclosed business segments at Omaxe with their share of revenue and profit, switchable between consolidated and standalone reporting.
Omaxe discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Omaxe Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Omaxe Ltd's investment case rests on 3 positive markers and 9 flagged concerns drawn from the latest reported filings.
Omaxe demonstrates strong promoter confidence with a significant holding of 74.14%, indicating stable leadership and a long-term commitment to the company's future direction and growth.
The broader 'Realty' sector, driven by urbanization and housing demand, presents potential for Omaxe to capitalize on market expansion if it can address its internal financial challenges.
Favorable government policies and infrastructure development in the 'Residential Commercial Projects' industry could stimulate demand, offering growth avenues for Omaxe.
The company exhibits severe profitability issues, with a negative Return on Equity of -506% and Return on Capital Employed of -61.4%, indicating significant value destruction for shareholders.
Omaxe reported a substantial quarterly net loss of -186 crores, representing a -26% decline from the previous quarter, highlighting persistent operational challenges and financial instability.
A high debt-to-equity ratio of 1.66 suggests significant financial leverage, increasing the company's risk profile and potentially limiting future investment or expansion capabilities.
The negative book value of -11.20 indicates that the company's liabilities exceed its assets, raising serious concerns about its intrinsic value and long-term financial viability.
Quarterly sales declined by -17.40% to 282 crores, reflecting a contraction in revenue generation and potential challenges in market demand or operational execution.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Omaxe Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Omaxe Ltd — derived from the live tape, not yesterday's close.
Omaxe Ltd last traded at ₹75.96 with an intraday range of ₹75.11–₹79 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 86.05 | +10.09 | +13.28% |
| R3 | 82.16 | +6.20 | +8.16% |
| R2 | 80.58 | +4.62 | +6.08% |
| R1 | 78.27 | +2.31 | +3.04% |
| PIVOT | 76.69 | 0.73 | 0.96% |
| CURRENT | 75.96 | — | — |
| S1 | 66.60 | -9.36 | -12.32% |
| S2 | 70.49 | -5.47 | -7.20% |
| S3 | 72.80 | -3.16 | -4.16% |
| S4 | 74.38 | -1.58 | -2.08% |
OMAXE is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 75.31 ~ 79
Trading Inside opening range
Daily traded volume and delivery percentage for Omaxe Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Omaxe Ltd stood at 24.1% of traded volume, against a 20-day average of 51.5%.
Filings Omaxe sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Omaxe files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 120 documents below.
Omaxe Limited has informed the Exchange about Copies of Newspaper Publications w.r.t. Transfer of Equity Shares and Dividend to Investor Education…
Rekha Goel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Omaxe Limited has informed the Exchange regarding 'De-registration of Rohtas Holding (Gulf) Limited '.
Guild Builders Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Jai Bhagwan Goel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Promoter, director and designated-employee transactions in Omaxe as reported to SEBI — buying and selling signals from the people who know the business best.
Omaxe insider activity below tracks 15 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Guild Builders Private Limited | Insider | 20 Apr 2026 | buy | +3.53 Cr | ₹35.26 Cr | ₹10.00 |
| Guild Builders Private Limited | Insider | 20 Apr 2026 | buy | +3.53 Cr | ₹35.26 Cr | ₹10.00 |
| Guild Builders Private Limited | Insider | 20 Apr 2026 | buy | +3.53 Cr | ₹35.26 Cr | ₹10.00 |
| Sunil Goel | Insider | 13 Mar 2025 | sell | −12.48 L | ₹1.25 Cr | ₹10.00 |
| Rohtas Goel | Insider | 13 Mar 2025 | buy | +12.48 L | ₹1.25 Cr | ₹10.00 |
| Rohtas Goel | Insider | 12 Mar 2025 | buy | +36.1 K | ₹3.61 L | ₹10.00 |
| Sunil Goel | Insider | 12 Mar 2025 | sell | −36.1 K | ₹3.61 L | ₹10.00 |
| Rohtas Goel | Insider | 27 Jan 2025 | buy | +13.04 L | ₹1.3 Cr | ₹10.00 |
| Sunil Goel | Insider | 27 Jan 2025 | sell | −13.04 L | ₹1.3 Cr | ₹10.00 |
| Rohtas Goel | Insider | 20 Dec 2024 | buy | +7.48 L | ₹74.8 L | ₹10.00 |
Every dividend, stock split and bonus issue Omaxe has declared, sequenced by announce and record date.
Omaxe corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Omaxe Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Omaxe Ltd operates in the Real Estate, listed as NSE: OMAXE, BSE: 532880.

OMAXE Limited is a prominent real estate development company operating within India. Their business model centers on creating and developing diverse real estate properties, catering to a broad spectrum of needs and market segments.
The company's portfolio is expansive and multifaceted, encompassing several key areas of real estate development. This includes residential projects, offering homes to individuals and families; commercial properties such as office spaces, designed to meet the demands of businesses of varying sizes; and retail spaces, including shopping malls, intended to attract consumers and provide retail opportunities.
Beyond these core areas, OMAXE also undertakes the development of large-scale integrated townships and hi-tech townships. These projects often involve the creation of self-contained communities offering a mix of residential, commercial, and recreational amenities. Furthermore, they participate in Public-Private Partnership (PPP) projects, collaborating with government entities to develop public infrastructure.
Other key areas of their development include the construction of SCOs (Shops, Commercial Offices), which are mixed-use properties combining retail and office spaces, and hospitality properties, such as hotels or resorts. Their portfolio even extends to developing public infrastructure and sports-related destinations, showcasing their diverse approach to real estate development.
Founded in 1987 and initially known as Omaxe Construction Limited, the company rebranded as Omaxe Limited in 2006. Currently based in New Delhi, India, OMAXE Limited is a subsidiary of Guild Builders Private Limited. Their long history and wide-ranging portfolio demonstrate a significant presence in the Indian real estate market.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Omaxe Ltd (OMAXE) is ₹75.96. Today, the stock has gained by ₹1.66 (2.23%), trading in a range of ₹75.11 to ₹79. The stock opened at ₹76.99 with a trading volume of 4,59,192 shares.
Omaxe Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,382 crores, P/E ratio of 0.00, ROE of 0.00%, and ROCE of -61.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Omaxe Ltd (OMAXE) is ₹0, while the 52-week low is ₹0. Currently trading at ₹75.96, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Omaxe Ltd stock at ₹75.96 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 0.00. Today's performance shows a gain of 2.23%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Omaxe Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹75.96, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Omaxe Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 0.00, ROE: 0.00%, ROCE: -61.40%, Dividend Yield: 0.00%, EPS: ₹-38.10, Book Value: ₹-30.46, and Debt-to-Equity: 0.00. The company's market cap stands at ₹1,382 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Omaxe Ltd stock opened at ₹76.99 and is currently trading at ₹75.96, showing a gain of ₹1.66 (2.23%). The intraday high is ₹79 and low is ₹75.11. The trading volume stands at 4,59,192 shares, indicating moderate market participation today.
Omaxe Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-38.10, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Omaxe Ltd (OMAXE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.